1. Enhancement of ciprofloxacin activity by incorporating it in solid lipid nanoparticles.
- Author
-
Alarifi, Saqer, Massadeh, Salam, Al-Agamy, Mohammed, Al Aamery, Manal, Al Bekairy, Abdulkareem, and Yassin, Alaa Eldeen
- Subjects
- *
CIPROFLOXACIN , *NANOPARTICLES , *LIPIDS , *PSEUDOMONAS aeruginosa , *ESCHERICHIA coli , *DRUG side effects , *ZETA potential - Abstract
Purpose: To incorporate ciprofloxacin (CIP) into solid lipid nanoparticles (SLN) in order to enhance its biopharmaceutical properties and antibacterial activity. Methods: A sonication melt-emulsification method was employed for the preparation of CIP-loaded SLN. The composition of the SLN was varied in order to investigate factors such as lipid type and combination ratio, drug to lipid ratio, and surfactant ratio. The produced SLN formulations were evaluated for their particle size and shape, zeta potential, and entrapment efficiency. In addition, the effect of SLN formulation composition on its drug release profile and antimicrobial activity against Escherichia coli, Pseudomonas Aeruginosa, and Staphylococcus Aureus was also investigated. Results: The generated nanoparticles had particle size in the range of 165 to 320 nm. The zetapotential values were generally low within ± 5. All formulations exhibited entrapment efficiency between 50 and 90 %. CIP release exhibited a biphasic release profile with a low burst phase, followed by uniform controlled-release behavior of various rates. SLN-loaded CIP exhibited one-fold reduction in minimum inhibitory concentration (MIC) and caused significant inhibition of all the three bacterial strains tested, when compared with pure CIP. Conclusion: Loading of CIP into SLN significantly enhances its antimicrobial activity in vitro which can translate to significant enhancement of therapeutic outcomes by minimizing the dose-dependent adverse and side effects and/or enhancing the antimicrobial spectrum of activity. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF